Genomic and Epigenomic Instability, Fragile Sites, Schizophrenia and Autism
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Increasing evidence links genomic and epigenomic instability, including multiple fragile sites regions to neuropsychiatric diseases including schizophrenia and autism. Cancer is the only other disease associated with multiple fragile site regions, and genome and epigenomic instability is a characteristic of cancer. Research on cancer is far more advanced than research on neuropsychiatric disease; hence, insight into neuropsychiatric disease may be derived from cancer research results. Towards this end, this article will review the evidence linking schizophrenia and other neuropsychiatric diseases (especially autism) to genomic and epigenomic instability, and fragile sites. The results of studies on genetic, epigenetic and environmental components of schizophrenia and autism point to the importance of the folate-methionine-transulfuration metabolic hub that is diseases also perturbed in cancer. The idea that the folate-methionine-transulfuration hub is important in neuropsychiatric is exciting because this hub present novel targets for drug development, suggests some drugs used in cancer may be useful in neuropsychiatric disease, and raises the possibility that nutrition interventions may influence the severity, presentation, or dynamics of disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DNA methylation landscapes: Provocative insights from epigenomics
Suzuki, M. M., & Bird, A. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2341 · Cited by 3,039
Genomic DNA methylation: the mark and its mediators.
Klose, R. J., & Bird, A. P. (2006) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.12.008 · Cited by 2,501 · cited 1×
“One methylated DNA binding family, consisting of the MeCP2, MBD1, MBD2, MBD3, and MBD4 proteins, has a conserved methyl-binding domain (MBD) and binds singly methylated CpG dinucleotides [44].”
BackgroundSchizophrenia: A Concise Overview of Incidence, Prevalence, and Mortality
McGrath, J., Saha, S., Chant, D., & Welham, J. (2008) · Epidemiologic Reviews · doi:10.1093/epirev/mxn001 · Cited by 2,280
Rare Structural Variants Disrupt Multiple Genes in Neurodevelopmental Pathways in Schizophrenia
Walsh, T., McClellan, J. M., McCarthy, S. E., Addington, A. M., Pierce, S. B., Cooper, G. M., Nord, A. S., Kusenda, M., Malhotra, D., Bhandari, A., et al. (2008) · Science · doi:10.1126/science.1155174 · Cited by 1,800
Common variants conferring risk of schizophrenia
†Genetic Risk and Outcome in Psychosis (GROUP), Stefansson, H., Ophoff, R. A., Steinberg, S., Andreassen, O. A., Cichon, S., Rujescu, D., Werge, T., Pietiläinen, O. P. H., Mors, O., et al. (2009) · Nature · doi:10.1038/nature08186 · Cited by 1,677 · cited 1×
“More recently, genome wide scanning of SNPs in association studies revealed an elevated rate of copy number variation (CNV) in schizophrenia [79-82], and a number of other neuropsychiatric diseases such as autism, mental retardation, bipolar disease, Rett syndrome, Tourette’s syndrome, Prader-Willi/Angelman syndrome e…”
BackgroundChen, J., Lipska, B. K., Halim, N., Ma, Q. D., Matsumoto, M., Melhem, S., Kolachana, B. S., Hyde, T. M., Herman, M. M., Apud, J., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/425589 · Cited by 1,675 · cited 1×
“The Met alleles is thermolabile, causing COMT enzyme activity in Met homozygotes to drop to approximately 1/3 the level of Val homozygotes at physiological temperature [53].”
BackgroundRare chromosomal deletions and duplications increase risk of schizophrenia
The International Schizophrenia Consortium (2008) · Nature · doi:10.1038/nature07239 · Cited by 1,475
Autism spectrum disorders: developmental disconnection syndromes
Geschwind, D. H., & Levitt, P. (2007) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2007.01.009 · Cited by 1,411
New nomenclature for chromatin-modifying enzymes
Allis, C. D., Berger, S. L., Cote, J., Dent, S., Jenuwien, T., Kouzarides, T., Pillus, L., Reinberg, D., Shi, Y., Shiekhattar, R., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.039 · Cited by 957
James, S. J., Cutler, P., Melnyk, S., Jernigan, S., Janak, L., Gaylor, D. W., & Neubrander, J. A. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.6.1611 · Cited by 955
The origins, patterns and implications of human spontaneous mutation
Crow, J. F. (2000) · Nature Reviews Genetics · doi:10.1038/35049558 · Cited by 928 · cited 2×
“However, neither the number of replication cycles nor the observed mutation rates [110-113] accounts for the exponential rather than linear increase in disease as a function age; hence, it was suggested that these mutations confer a selection growth advantage to sperm.”
BackgroundCopy-number variations associated with neuropsychiatric conditions
Cook Jr, E. H., & Scherer, S. W. (2008) · Nature · doi:10.1038/nature07458 · Cited by 659
Advancing Paternal Age and the Risk of Schizophrenia
Malaspina, D., Harlap, S., Fennig, S., Heiman, D., Nahon, D., Feldman, D., & Susser, E. S. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.4.361 · Cited by 562
Reelin promoter hypermethylation in schizophrenia
Grayson, D. R., Jia, X., Chen, Y., Sharma, R. P., Mitchell, C. P., Guidotti, A., & Costa, E. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503736102 · Cited by 553 · cited 1×
“This is consistent with results [59, 60] that hyper-methylation of the RELN promoter and subsequent low expression of the reelin gene in the frontal lobes is correlated with schizophrenia.”
ResultDetection and interpretation of altered methylation patterns in cancer cells
Ushijima, T. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1571 · Cited by 483 · cited 1×
“The number and location of methylated CpG sites in promoter regions usually, but not always, correlates with gene expression in vivo [24, 25, 36, 37, 38, 42].”
BackgroundHypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder
Abdolmaleky, H. M., Cheng, K.-H., Faraone, S. V., Wilcox, M., Glatt, S. J., Gao, F., Smith, C. L., Shafa, R., Aeali, B., Carnevale, J., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl253 · Cited by 462 · cited 2×
“Our experiments [2, 3] studied promoter methylation and gene expression levels in Brodmann Area 46 (DLPFC) of normal versus neuropsychiatric (schizophrenia and bipolar) individuals (Fig.”
BackgroundSelf-citationHomocysteine and folate metabolism in depression
Bottiglieri, T. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.06.021 · Cited by 459 · cited 1×
“[123, 124]) including schizophrenia and mood disorders [125-129], and are common in patients with psychopathology [130].”
BackgroundGuilmatre, A., Dubourg, C., Mosca, A.-L., Legallic, S., Goldenberg, A., Drouin-Garraud, V., Layet, V., Rosier, A., Briault, S., Bonnet-Brilhault, F., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.80 · Cited by 429
Woo, T.-U. W., Walsh, J. P., & Benes, F. M. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.7.649 · Cited by 411
Epigenetics of autism spectrum disorders
Schanen, N. C. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl213 · Cited by 341
Novel submicroscopic chromosomal abnormalities detected in autism spectrum disorder.
Christian, S. L., Brune, C. W., Sudi, J., Kumar, R. A., Liu, S., Karamohamed, S., Badner, J. A., Matsui, S., Conroy, J., McQuaid, D., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.01.009 · Cited by 299
Effect of Catechol- O -Methyltransferase val 158 met Genotype on Attentional Control
Blasi, G., Mattay, V. S., Bertolino, A., Elvevåg, B., Callicott, J. H., Das, S., Kolachana, B. S., Egan, M. F., Goldberg, T. E., & Weinberger, D. R. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0476-05.2005 · Cited by 294 · cited 1×
“COMT hyperactivity (from the Val allele) has been linked to poor working memory as well as disturbed executive function and attention [54-58].”
BackgroundRole of S-adenosyl-l-methionine in the treatment of depression: a review of the evidence,,,
Mischoulon, D., & Fava, M. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.5.1158s · Cited by 285 · cited 1×
“[123, 124]) including schizophrenia and mood disorders [125-129], and are common in patients with psychopathology [130].”
BackgroundComparative genomics of autism and schizophrenia
Crespi, B., Stead, P., & Elliot, M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906080106 · Cited by 262
The Genetic Deconstruction of Psychosis
Owen, M. J., Craddock, N., & Jablensky, A. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm053 · Cited by 262
Sebat, J., Levy, D. L., & McCarthy, S. E. (2009) · Trends in Genetics · doi:10.1016/j.tig.2009.10.004 · Cited by 260
Epigenetic Mediation of Environmental Influences in Major Psychotic Disorders
Rutten, B. P. F., & Mill, J. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp104 · Cited by 244
Groc, L., Choquet, D., Stephenson, F. A., Verrier, D., Manzoni, O. J., & Chavis, P. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1772-07.2007 · Cited by 225
Abdolmaleky, H. M., Smith, C. L., Faraone, S. V., Shafa, R., Stone, W., Glatt, S. J., & Tsuang, M. T. (2004) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.20142 · Cited by 216 · cited 3×
“We and others have previously reviewed [24, 25, 50, 51] the connection between epigenetic modifications and neurological disease, including the effect of folic acid (a source of methyl groups for epigenetic modifications) metabolism on psychotic symptoms, and the co-morbidity of psychosis with diseases clearly linked…”
BackgroundSelf-citationHistone modifications, DNA methylation, and Schizophrenia
Gavin, D. P., & Sharma, R. P. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.10.010 · Cited by 121
Maternal serum folate and zinc concentrations and their relationships to pregnancy outcome
Tamura, T., Goldenberg, R., Freeberg, L., Cliver, S., Cutter, G., & Hoffman, H. (1992) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/56.2.365 · Cited by 119 · cited 1×
“Maternal exposure to nutritional insults leads to persistent physiological and biochemical effects on the offspring [118-121].”
Background
Cited by
Misiak, B., Szmida, E., Karpiński, P., Loska, O., Sąsiadek, M. M., & Frydecka, D. (2015) · Epigenomics · doi:10.2217/epi.15.68 · Cited by 77
Epigenetics and gene expression profile in first-episode psychosis: the role of childhood trauma
Tomassi, S., & Tosato, S. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.10.018 · Cited by 51
“CTassociated lower DNA methylation could have a functional relevance to gene regulation and/or be responsible for genomic instability, which has been previously observed in schizophrenia (Shimabukuro et al., 2007; Smith et al., 2010).”
Dietary Patterns of Children with Autism Spectrum Disorder: A Study Based in Egypt
Meguid, N., Anwar, M., Zaki, S., Kandeel, W., Ahmed, N., & Tewfik, I. (2015) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2015.051 · Cited by 35
Fragile sites, chromosomal lesions, tandem repeats, and disease
Mirceta, M., Shum, N., Schmidt, M. H. M., & Pearson, C. E. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.985975 · Cited by 30
“In particular, 28 CFSs contain genes associated with schizophrenia (reviewed in (Smith et al., 2010).”
Background
Metadata
- Authors
- Smith, C., Bolton, A., & Nguyen, G.
- Venue
- Current Genomics
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2010-09-01
- Volume
- 11
- Issue
- 6
- Pages
- 447-469
- ISSN
- 1389-2029 (ISSN-L)
- OpenAlex
- W2046323265
- Cited by
- 73
- References
- 31
- FWCI
- 3.59
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.